Background
Effective treatment strategies for hepatocellular carcinoma (HCC) remain limited. Identification of additional therapies remains paramount as currently available agents have resulted in marginal improvements in overall survival.
Publications
Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinoma identifies potential novel therapeutic options
– Caris Life Sciences
Download Publication